Gupta Rishi

CIK 00015373706 companiesMOUNTAIN VIEW, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001537370

Recent Transactions

38 trades

Disposition from Tender
Turnstone Biologics Corp.
Common Stock
2025-08-08−3,099,265→ 0 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+20,491→ 20,491 total
Award
Turnstone Biologics Corp.
Stock Option (Right to Buy)
2024-06-03+12,770→ 12,770 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-16$22.14/sh−33,300→ 254,814 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-05-16$22.14/sh−1,000,000→ 7,663,349 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+23,364→ 23,364 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+16,835→ 16,835 total
Award
Turnstone Biologics Corp.
Stock Option (Right to Buy)
2023-10-16+25,540→ 25,540 total
Purchase
Turnstone Biologics Corp.
Common Stock
2023-07-20$12.00/sh+416,666→ 3,099,265 total
Conversion
Turnstone Biologics Corp.
Series B-2 Preferred Stock
2023-07-20−1,249,829→ 0 total
Conversion
Turnstone Biologics Corp.
Series B-1 Preferred Stock
2023-07-20−937,372→ 0 total
Conversion
Turnstone Biologics Corp.
Series D Preferred Stock
2023-07-20−229,158→ 0 total
Conversion
Turnstone Biologics Corp.
Common Stock
2023-07-20+2,682,599→ 2,682,599 total
Conversion
Turnstone Biologics Corp.
Series C Preferred Stock
2023-07-20−266,240→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Options (Right to Buy)
2023-05-17−2,125→ 0 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-05-17$4.28/sh+2,125→ 8,663,349 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2023-05-15$20.00/sh−345,313→ 3,777,778 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2023-05-15$21.96/sh−14,400→ 4,123,091 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2023-05-12$21.64/sh−43,200→ 4,137,491 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2023-05-11$22.26/sh−80,000→ 4,180,691 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2023-04-28+96,000→ 96,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2023-02-23+27,567→ 27,567 total
Award
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-02-23+7,611,458→ 7,611,458 total
Award
Enliven Therapeutics, Inc.$ELVN
Common Stock
2023-02-23+288,114→ 288,114 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2022-12-23$24.11/sh−92,992→ 34,085,528 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2022-12-23$23.23/sh−1,116,048→ 34,178,520 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2022-12-23$22.27/sh−961,328→ 35,294,568 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2022-12-22$22.07/sh−684,696→ 36,255,896 total
Sale
Verona Pharma plc$VRNA
Ordinary Shares
2022-12-22$21.71/sh−3,284,800→ 36,940,592 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2022-04-28+200,000→ 200,000 total
Award
Verona Pharma plc$VRNA
Share Options (Right to Buy)
2021-08-09+64,000→ 64,000 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2016-05-19+32,069→ 32,069 total
Conversion
Dimension Therapeutics, Inc.
Common Stock
2015-10-27+3,250,085→ 3,250,085 total
Conversion
Dimension Therapeutics, Inc.
Common Stock
2015-10-27+1,947,613→ 5,197,698 total
Purchase
Dimension Therapeutics, Inc.
Common Stock
2015-10-27$13.00/sh+200,000→ 5,397,698 total
Conversion
Dimension Therapeutics, Inc.
Series A Preferred Stock
2015-10-27−9,500,000→ 0 total
Conversion
Dimension Therapeutics, Inc.
Series B Preferred Stock
2015-10-27−5,692,874→ 0 total
Award
ChemoCentryx, Inc.
Stock Option (right to buy)
2012-06-22+12,500→ 12,500 total

Companies

Recent Filings

Address

C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE

MOUNTAIN VIEW, CA, 94043

View on SEC.gov